{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,13]],"date-time":"2026-11-13T14:17:59Z","timestamp":1794579479360,"version":"4.9.1"},"reference-count":104,"publisher":"Springer Science and Business Media LLC","issue":"10","license":[{"start":{"date-parts":[[2025,10,1]],"date-time":"2025-10-01T00:00:00Z","timestamp":1759276800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2025,10,1]],"date-time":"2025-10-01T00:00:00Z","timestamp":1759276800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"funder":[{"DOI":"10.13039\/501100010029","name":"Taishan Scholar Foundation of Shandong Province","doi-asserted-by":"publisher","award":["tsqn202211375"],"award-info":[{"award-number":["tsqn202211375"]}],"id":[{"id":"10.13039\/501100010029","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["J Neurol"],"published-print":{"date-parts":[[2025,10]]},"DOI":"10.1007\/s00415-025-13434-0","type":"journal-article","created":{"date-parts":[[2025,10,13]],"date-time":"2025-10-13T19:02:57Z","timestamp":1760382177000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":7,"title":["The role of APOE \u03b54 in modulating the relationship between non-genetic risk factors and dementia: a system review and meta-analysis"],"prefix":"10.1007","volume":"272","author":[{"given":"Xiao-Tong","family":"Huang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Liang-Yu","family":"Huang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chen-Chen","family":"Tan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jie-Mei","family":"Wei","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xin-Hao","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lan","family":"Tan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3310-5875","authenticated-orcid":false,"given":"Wei","family":"Xu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,10,13]]},"reference":[{"key":"13434_CR1","doi-asserted-by":"publisher","DOI":"10.1016\/j.nbas.2023.100102","volume":"4","author":"B Liemisa","year":"2023","unstructured":"Liemisa B, Newbury SF, Novy MJ et al (2023) Brain apolipoprotein E levels in mice challenged by a Western diet increase in an allele-dependent manner. Aging Brain 4:100102. https:\/\/doi.org\/10.1016\/j.nbas.2023.100102","journal-title":"Aging Brain"},{"issue":"1","key":"13434_CR2","doi-asserted-by":"publisher","DOI":"10.1186\/s13195-024-01512-w","volume":"16","author":"ZE Neale","year":"2024","unstructured":"Neale ZE, Fonda JR, Miller MW et al (2024) Subjective cognitive concerns, APOE \u03b54, PTSD symptoms, and risk for dementia among older veterans. Alzheimers Res Ther 16(1):143. https:\/\/doi.org\/10.1186\/s13195-024-01512-w","journal-title":"Alzheimers Res Ther"},{"key":"13434_CR3","doi-asserted-by":"publisher","DOI":"10.1172\/jci169131","author":"C Wang","year":"2023","unstructured":"Wang C, Nambiar A, Strickland MR et al (2023) APOE-\u03b54 synergizes with sleep disruption to accelerate A\u03b2 deposition and A\u03b2-associated tau seeding and spreading. J Clin Invest. https:\/\/doi.org\/10.1172\/jci169131","journal-title":"J Clin Invest"},{"issue":"7","key":"13434_CR4","doi-asserted-by":"publisher","first-page":"379","DOI":"10.1038\/s41582-024-00985-5","volume":"20","author":"I Fyfe","year":"2024","unstructured":"Fyfe I (2024) APOE \u03b14 homozygosity \u2013 a genetic form of Alzheimer disease? Nat Rev Neurol 20(7):379. https:\/\/doi.org\/10.1038\/s41582-024-00985-5","journal-title":"Nat Rev Neurol"},{"issue":"5","key":"13434_CR5","doi-asserted-by":"publisher","first-page":"1284","DOI":"10.1038\/s41591-024-02931-w","volume":"30","author":"J Fortea","year":"2024","unstructured":"Fortea J, Pegueroles J, Alcolea D et al (2024) APOE4 homozygosity represents a distinct genetic form of Alzheimer\u2019s disease. Nat Med 30(5):1284\u20131291. https:\/\/doi.org\/10.1038\/s41591-024-02931-w","journal-title":"Nat Med"},{"issue":"1","key":"13434_CR6","doi-asserted-by":"publisher","DOI":"10.1186\/s13195-020-00712-4","volume":"12","author":"S Emrani","year":"2020","unstructured":"Emrani S, Arain HA, DeMarshall C, Nuriel T (2020) APOE4 is associated with cognitive and pathological heterogeneity in patients with Alzheimer\u2019s disease: a systematic review. Alzheimers Res Ther 12(1):141. https:\/\/doi.org\/10.1186\/s13195-020-00712-4","journal-title":"Alzheimers Res Ther"},{"issue":"3","key":"13434_CR7","doi-asserted-by":"publisher","first-page":"241","DOI":"10.1016\/s1474-4422(10)70325-2","volume":"10","author":"PB Verghese","year":"2011","unstructured":"Verghese PB, Castellano JM, Holtzman DM (2011) Apolipoprotein E in Alzheimer\u2019s disease and other neurological disorders. Lancet Neurol 10(3):241\u2013252. https:\/\/doi.org\/10.1016\/s1474-4422(10)70325-2","journal-title":"Lancet Neurol"},{"issue":"1","key":"13434_CR8","doi-asserted-by":"publisher","first-page":"61","DOI":"10.1007\/s00011-025-02016-5","volume":"74","author":"R Bassal","year":"2025","unstructured":"Bassal R, Rivkin-Natan M, Rabinovich A, Michaelson DM, Frenkel D, Pinkas-Kramarski R (2025) APOE4 impairs autophagy and A\u03b2 clearance by microglial cells. Inflamm Res 74(1):61. https:\/\/doi.org\/10.1007\/s00011-025-02016-5","journal-title":"Inflamm Res"},{"issue":"1","key":"13434_CR9","doi-asserted-by":"publisher","first-page":"458","DOI":"10.1186\/s12964-024-01832-2","volume":"22","author":"M Yesiltepe","year":"2024","unstructured":"Yesiltepe M, Yin T, Tambini M et al (2024) Analysis of early effects of human APOE isoforms on Alzheimer\u2019s disease and type III hyperlipoproteinemia pathways using knock-in rat models with humanized APP and APOE. Cell Commun Signal 22(1):458. https:\/\/doi.org\/10.1186\/s12964-024-01832-2","journal-title":"Cell Commun Signal"},{"key":"13434_CR10","doi-asserted-by":"publisher","DOI":"10.5582\/bst.2025.01148","author":"J Chen","year":"2025","unstructured":"Chen J, Zhao S, Zhou Y, Wang L, Chen Q, Zheng K (2025) APOE4 reprograms microglial lipid metabolism in Alzheimer\u2019s disease: mechanisms and therapeutic implications. Biosci Trends. https:\/\/doi.org\/10.5582\/bst.2025.01148","journal-title":"Biosci Trends"},{"issue":"2","key":"13434_CR11","doi-asserted-by":"publisher","first-page":"347","DOI":"10.1038\/s12276-023-00935-z","volume":"55","author":"C Wang","year":"2023","unstructured":"Wang C, Lu J, Sha X, Qiu Y, Chen H, Yu Z (2023) TRPV1 regulates ApoE4-disrupted intracellular lipid homeostasis and decreases synaptic phagocytosis by microglia. Exp Mol Med 55(2):347\u2013363. https:\/\/doi.org\/10.1038\/s12276-023-00935-z","journal-title":"Exp Mol Med"},{"issue":"7","key":"13434_CR12","doi-asserted-by":"publisher","DOI":"10.1111\/jnc.70162","volume":"169","author":"F Cheng","year":"2025","unstructured":"Cheng F, Fransson L, Mani K (2025) Modulation of pTau181 by Glypican-1-derived heparan sulfate in human neural progenitor cells and ApoE4-expressing induced neurons. J Neurochem 169(7):e70162. https:\/\/doi.org\/10.1111\/jnc.70162","journal-title":"J Neurochem"},{"issue":"1","key":"13434_CR13","doi-asserted-by":"publisher","first-page":"99","DOI":"10.1186\/s40478-023-01581-2","volume":"11","author":"T Williams","year":"2023","unstructured":"Williams T, Bathe T, Vo Q et al (2023) Humanized APOE genotypes influence lifespan independently of tau aggregation in the P301S mouse model of tauopathy. Acta Neuropathol Commun 11(1):99. https:\/\/doi.org\/10.1186\/s40478-023-01581-2","journal-title":"Acta Neuropathol Commun"},{"issue":"1","key":"13434_CR14","doi-asserted-by":"publisher","first-page":"147","DOI":"10.1186\/s12974-025-03470-y","volume":"22","author":"M Hell\u00e9n","year":"2025","unstructured":"Hell\u00e9n M, Weert I, M\u00fcller SA et al (2025) Inflammation-induced lysosomal dysfunction in human iPSC-derived microglia is exacerbated by APOE 4\/4 genotype. J Neuroinflammation 22(1):147. https:\/\/doi.org\/10.1186\/s12974-025-03470-y","journal-title":"J Neuroinflammation"},{"issue":"3","key":"13434_CR15","doi-asserted-by":"publisher","DOI":"10.1016\/j.celrep.2023.112196","volume":"42","author":"S Lee","year":"2023","unstructured":"Lee S, Devanney NA, Golden LR et al (2023) ApoE modulates microglial immunometabolism in response to age, amyloid pathology, and inflammatory challenge. Cell Rep 42(3):112196. https:\/\/doi.org\/10.1016\/j.celrep.2023.112196","journal-title":"Cell Rep"},{"key":"13434_CR16","doi-asserted-by":"publisher","DOI":"10.3390\/ijms25115754","author":"MB Grenon","year":"2024","unstructured":"Grenon MB, Papavergi MT, Bathini P, Sadowski M, Lemere CA (2024) Temporal characterization of the amyloidogenic APPswe\/PS1dE9;hAPOE4 mouse model of Alzheimer\u2019s disease. Int J Mol Sci. https:\/\/doi.org\/10.3390\/ijms25115754","journal-title":"Int J Mol Sci"},{"issue":"12","key":"13434_CR17","doi-asserted-by":"publisher","first-page":"2104","DOI":"10.1038\/s41593-023-01480-8","volume":"26","author":"MR Nelson","year":"2023","unstructured":"Nelson MR, Liu P, Agrawal A et al (2023) The APOE-R136S mutation protects against APOE4-driven Tau pathology, neurodegeneration and neuroinflammation. Nat Neurosci 26(12):2104\u20132121. https:\/\/doi.org\/10.1038\/s41593-023-01480-8","journal-title":"Nat Neurosci"},{"issue":"3","key":"13434_CR18","doi-asserted-by":"publisher","first-page":"1331","DOI":"10.3233\/jad-201606","volume":"81","author":"YY Wang","year":"2021","unstructured":"Wang YY, Ge YJ, Tan CC, Cao XP, Tan L, Xu W (2021) The proportion of APOE4 carriers among non-demented individuals: a pooled analysis of 389,000 community-dwellers. J Alzheimers Dis 81(3):1331\u20131339. https:\/\/doi.org\/10.3233\/jad-201606","journal-title":"J Alzheimers Dis"},{"issue":"11","key":"13434_CR19","doi-asserted-by":"publisher","first-page":"643","DOI":"10.1038\/s41582-022-00714-w","volume":"18","author":"L Migliore","year":"2022","unstructured":"Migliore L, Copped\u00e8 F (2022) Gene-environment interactions in Alzheimer disease: the emerging role of epigenetics. Nat Rev Neurol 18(11):643\u2013660. https:\/\/doi.org\/10.1038\/s41582-022-00714-w","journal-title":"Nat Rev Neurol"},{"issue":"2","key":"13434_CR20","doi-asserted-by":"publisher","first-page":"106","DOI":"10.1038\/nrneurol.2012.263","volume":"9","author":"CC Liu","year":"2013","unstructured":"Liu CC, Liu CC, Kanekiyo T, Xu H, Bu G (2013) Apolipoprotein E and Alzheimer disease: risk, mechanisms and therapy. Nat Rev Neurol 9(2):106\u2013118. https:\/\/doi.org\/10.1038\/nrneurol.2012.263","journal-title":"Nat Rev Neurol"},{"issue":"1","key":"13434_CR21","doi-asserted-by":"publisher","first-page":"261","DOI":"10.1038\/s41392-022-01118-4","volume":"7","author":"H Zhang","year":"2022","unstructured":"Zhang H, Shao L, Lin Z et al (2022) APOE interacts with ACE2 inhibiting SARS-CoV-2 cellular entry and inflammation in COVID-19 patients. Signal Transduct Target Ther 7(1):261. https:\/\/doi.org\/10.1038\/s41392-022-01118-4","journal-title":"Signal Transduct Target Ther"},{"issue":"12","key":"13434_CR22","doi-asserted-by":"publisher","first-page":"1284","DOI":"10.1001\/jamaneurol.2023.3599","volume":"80","author":"ME Belloy","year":"2023","unstructured":"Belloy ME, Andrews SJ, Le Guen Y et al (2023) APOE genotype and Alzheimer disease risk across age, sex, and population ancestry. JAMA Neurol 80(12):1284\u20131294. https:\/\/doi.org\/10.1001\/jamaneurol.2023.3599","journal-title":"JAMA Neurol"},{"issue":"16","key":"13434_CR23","doi-asserted-by":"publisher","first-page":"1349","DOI":"10.1001\/jama.1997.03550160069041","volume":"278","author":"LA Farrer","year":"1997","unstructured":"Farrer LA, Cupples LA, Haines JL et al (1997) Effects of age, sex, and ethnicity on the association between apolipoprotein E genotype and Alzheimer disease. A meta-analysis. APOE and Alzheimer Disease Meta Analysis Consortium. JAMA 278(16):1349\u20131356","journal-title":"JAMA"},{"issue":"6","key":"13434_CR24","doi-asserted-by":"publisher","first-page":"883","DOI":"10.1667\/rr0642.1","volume":"166","author":"L Villasana","year":"2006","unstructured":"Villasana L, Acevedo S, Poage C, Raber J (2006) Sex- and APOE isoform-dependent effects of radiation on cognitive function. Radiat Res 166(6):883\u2013891. https:\/\/doi.org\/10.1667\/rr0642.1","journal-title":"Radiat Res"},{"issue":"3","key":"13434_CR25","doi-asserted-by":"publisher","first-page":"303","DOI":"10.1136\/jnnp-2021-326677","volume":"93","author":"R Koncz","year":"2022","unstructured":"Koncz R, Thalamuthu A, Wen W et al (2022) The heritability of amyloid burden in older adults: the Older Australian twins study. J Neurol Neurosurg Psychiatry 93(3):303\u2013308. https:\/\/doi.org\/10.1136\/jnnp-2021-326677","journal-title":"J Neurol Neurosurg Psychiatry"},{"issue":"4","key":"13434_CR26","doi-asserted-by":"publisher","first-page":"511","DOI":"10.1093\/ageing\/afw068","volume":"45","author":"DM Lyall","year":"2016","unstructured":"Lyall DM, Ward J, Ritchie SJ et al (2016) Alzheimer disease genetic risk factor APOE e4 and cognitive abilities in 111,739 UK Biobank participants. Age Ageing 45(4):511\u2013517. https:\/\/doi.org\/10.1093\/ageing\/afw068","journal-title":"Age Ageing"},{"issue":"9","key":"13434_CR27","doi-asserted-by":"publisher","first-page":"2946","DOI":"10.1093\/brain\/awae156","volume":"147","author":"F Chen","year":"2024","unstructured":"Chen F, Zhao J, Meng F, He F, Ni J, Fu Y (2024) The vascular contribution of apolipoprotein E to Alzheimer\u2019s disease. Brain 147(9):2946\u20132965. https:\/\/doi.org\/10.1093\/brain\/awae156","journal-title":"Brain"},{"issue":"1","key":"13434_CR28","doi-asserted-by":"publisher","DOI":"10.1093\/braincomms\/fcac035","volume":"4","author":"AA Tsiknia","year":"2022","unstructured":"Tsiknia AA, Reas E, Bangen KJ et al (2022) Sex and APOE \u025b4 modify the effect of cardiovascular risk on tau in cognitively normal older adults. Brain Commun 4(1):fcac035. https:\/\/doi.org\/10.1093\/braincomms\/fcac035","journal-title":"Brain Commun"},{"issue":"6b","key":"13434_CR29","doi-asserted-by":"publisher","first-page":"2762","DOI":"10.1111\/j.1582-4934.2008.00296.x","volume":"12","author":"M Kivipelto","year":"2008","unstructured":"Kivipelto M, Rovio S, Ngandu T et al (2008) Apolipoprotein E epsilon4 magnifies lifestyle risks for dementia: a population-based study. J Cell Mol Med 12(6b):2762\u20132771. https:\/\/doi.org\/10.1111\/j.1582-4934.2008.00296.x","journal-title":"J Cell Mol Med"},{"issue":"15","key":"13434_CR30","doi-asserted-by":"publisher","first-page":"2749","DOI":"10.1021\/acschemneuro.1c00295","volume":"12","author":"E Angelopoulou","year":"2021","unstructured":"Angelopoulou E, Paudel YN, Papageorgiou SG, Piperi C (2021) APOE genotype and Alzheimer\u2019s disease: the influence of lifestyle and environmental factors. ACS Chem Neurosci 12(15):2749\u20132764. https:\/\/doi.org\/10.1021\/acschemneuro.1c00295","journal-title":"ACS Chem Neurosci"},{"issue":"2","key":"13434_CR31","doi-asserted-by":"publisher","first-page":"422","DOI":"10.1111\/ene.15160","volume":"29","author":"L Li","year":"2022","unstructured":"Li L, Xu W, Tan CC et al (2022) A gene-environment interplay between omega-3 supplementation and APOE \u03b54 provides insights for Alzheimer\u2019s disease precise prevention amongst high-genetic-risk population. Eur J Neurol 29(2):422\u2013431. https:\/\/doi.org\/10.1111\/ene.15160","journal-title":"Eur J Neurol"},{"key":"13434_CR32","doi-asserted-by":"publisher","first-page":"1412006","DOI":"10.3389\/fnagi.2024.1412006","volume":"16","author":"KE Foley","year":"2024","unstructured":"Foley KE, Wilcock DM (2024) Three major effects of APOE(\u03b54) on A\u03b2 immunotherapy induced ARIA. Front Aging Neurosci 16:1412006. https:\/\/doi.org\/10.3389\/fnagi.2024.1412006","journal-title":"Front Aging Neurosci"},{"issue":"1","key":"13434_CR33","doi-asserted-by":"publisher","first-page":"89","DOI":"10.1186\/s13643-021-01626-4","volume":"10","author":"MJ Page","year":"2021","unstructured":"Page MJ, McKenzie JE, Bossuyt PM et al (2021) The PRISMA 2020 statement: an updated guideline for reporting systematic reviews. Syst Rev 10(1):89. https:\/\/doi.org\/10.1186\/s13643-021-01626-4","journal-title":"Syst Rev"},{"issue":"11","key":"13434_CR34","doi-asserted-by":"publisher","first-page":"1201","DOI":"10.1136\/jnnp-2019-321913","volume":"91","author":"JT Yu","year":"2020","unstructured":"Yu JT, Xu W, Tan CC et al (2020) Evidence-based prevention of Alzheimer\u2019s disease: systematic review and meta-analysis of 243 observational prospective studies and 153 randomised controlled trials. J Neurol Neurosurg Psychiatry 91(11):1201\u20131209. https:\/\/doi.org\/10.1136\/jnnp-2019-321913","journal-title":"J Neurol Neurosurg Psychiatry"},{"issue":"1","key":"13434_CR35","doi-asserted-by":"publisher","first-page":"90","DOI":"10.1016\/j.cmpb.2009.11.005","volume":"98","author":"N Orsini","year":"2010","unstructured":"Orsini N (2010) From floated to conventional confidence intervals for the relative risks based on published dose-response data. Comput Methods Programs Biomed 98(1):90\u201393. https:\/\/doi.org\/10.1016\/j.cmpb.2009.11.005","journal-title":"Comput Methods Programs Biomed"},{"key":"13434_CR36","doi-asserted-by":"publisher","first-page":"36","DOI":"10.1016\/j.jclinepi.2017.10.005","volume":"93","author":"R Brignardello-Petersen","year":"2018","unstructured":"Brignardello-Petersen R, Bonner A, Alexander PE et al (2018) Advances in the GRADE approach to rate the certainty in estimates from a network meta-analysis. J Clin Epidemiol 93:36\u201344. https:\/\/doi.org\/10.1016\/j.jclinepi.2017.10.005","journal-title":"J Clin Epidemiol"},{"issue":"4","key":"13434_CR37","doi-asserted-by":"publisher","first-page":"407","DOI":"10.1016\/j.jclinepi.2010.07.017","volume":"64","author":"GH Guyatt","year":"2011","unstructured":"Guyatt GH, Oxman AD, Vist G et al (2011) Grade guidelines: 4. rating the quality of evidence\u2013study limitations (risk of bias). J Clin Epidemiol 64(4):407\u2013415. https:\/\/doi.org\/10.1016\/j.jclinepi.2010.07.017","journal-title":"J Clin Epidemiol"},{"key":"13434_CR38","doi-asserted-by":"publisher","unstructured":"Perleth M, Langer G, Meerpohl JJ, Gartlehner G, Kaminski-Hartenthaler A, Sch\u00fcnemann HJ (2012) GRADE Leitlinien: 7. Einsch\u00e4tzung der Qualit\u00e4t der Evidenz \u2013 Inkonsistenz (GRADE guidelines: 7. Rating the quality of evidence \u2013 inconsistency). Z Evid Fortbild Qual Gesundhwes 106(10):733\u2013744. https:\/\/doi.org\/10.1016\/j.zefq.2012.10.018","DOI":"10.1016\/j.zefq.2012.10.018"},{"key":"13434_CR39","doi-asserted-by":"publisher","unstructured":"Kulig M, Perleth M, Langer G et al. (2012) GRADE guidelines: 6. Rating the quality of evidence: imprecision (GRADE Leitlinien: 6. Einsch\u00e4tzung der Qualit\u00e4t der Evidenz \u2013 Unzureichende Pr\u00e4zision). Z Evid Fortbild Qual Gesundhwes 106(9):677\u2013688. https:\/\/doi.org\/10.1016\/j.zefq.2012.10.016","DOI":"10.1016\/j.zefq.2012.10.016"},{"key":"13434_CR40","doi-asserted-by":"publisher","unstructured":"Rasch A, Perleth M, Langer G et al. (2012) GRADE Leitlinien: 8. Einsch\u00e4tzung der Qualit\u00e4t der Evidenz \u2013 Indirektheit (GRADE guidelines: 8. Rating the quality of evidence \u2013 indirectness). Z Evid Fortbild Qual Gesundhwes 106(10):745\u2013753. https:\/\/doi.org\/10.1016\/j.zefq.2012.10.019","DOI":"10.1016\/j.zefq.2012.10.019"},{"key":"13434_CR41","doi-asserted-by":"publisher","unstructured":"Nolting A, Perleth M, Langer G et al. (2012) GRADE Leitlinien: 5. Einsch\u00e4tzung der Qualit\u00e4t der Evidenz \u2013 Publikationsbias (GRADE guidelines: 5. Rating the quality of evidence: publication bias). Z Evid Fortbild Qual Gesundhwes 106(9):670\u2013676. https:\/\/doi.org\/10.1016\/j.zefq.2012.10.015","DOI":"10.1016\/j.zefq.2012.10.015"},{"issue":"7414","key":"13434_CR42","doi-asserted-by":"publisher","first-page":"557","DOI":"10.1136\/bmj.327.7414.557","volume":"327","author":"JP Higgins","year":"2003","unstructured":"Higgins JP, Thompson SG, Deeks JJ, Altman DG (2003) Measuring inconsistency in meta-analyses. BMJ 327(7414):557\u2013560. https:\/\/doi.org\/10.1136\/bmj.327.7414.557","journal-title":"BMJ"},{"issue":"11","key":"13434_CR43","doi-asserted-by":"publisher","first-page":"1539","DOI":"10.1002\/sim.1186","volume":"21","author":"JP Higgins","year":"2002","unstructured":"Higgins JP, Thompson SG (2002) Quantifying heterogeneity in a meta-analysis. Stat Med 21(11):1539\u20131558. https:\/\/doi.org\/10.1002\/sim.1186","journal-title":"Stat Med"},{"issue":"7806","key":"13434_CR44","doi-asserted-by":"publisher","first-page":"31","DOI":"10.1038\/d41586-020-01152-8","volume":"581","author":"M Ishii","year":"2020","unstructured":"Ishii M, Iadecola C (2020) Risk factor for Alzheimer\u2019s disease breaks the blood-brain barrier. Nature 581(7806):31\u201332. https:\/\/doi.org\/10.1038\/d41586-020-01152-8","journal-title":"Nature"},{"key":"13434_CR45","doi-asserted-by":"publisher","first-page":"54","DOI":"10.1016\/j.bbi.2024.05.019","volume":"120","author":"BH Lee","year":"2024","unstructured":"Lee BH, Cevizci M, Lieblich SE et al (2024) Exploring the parity paradox: differential effects on neuroplasticity and inflammation by APOEe4 genotype at middle age. Brain Behav Immun 120:54\u201370. https:\/\/doi.org\/10.1016\/j.bbi.2024.05.019","journal-title":"Brain Behav Immun"},{"issue":"23","key":"13434_CR46","doi-asserted-by":"publisher","first-page":"e2404","DOI":"10.1212\/wnl.0000000000009582","volume":"94","author":"J Yin","year":"2020","unstructured":"Yin J, Reiman EM, Beach TG et al (2020) Effect of ApoE isoforms on mitochondria in Alzheimer disease. Neurology 94(23):e2404\u2013e2411. https:\/\/doi.org\/10.1212\/wnl.0000000000009582","journal-title":"Neurology"},{"issue":"1","key":"13434_CR47","doi-asserted-by":"publisher","first-page":"61","DOI":"10.1111\/j.1747-4949.2011.00731.x","volume":"7","author":"R Sahathevan","year":"2012","unstructured":"Sahathevan R, Brodtmann A, Donnan GA (2012) Dementia, stroke, and vascular risk factors; a review. Int J Stroke 7(1):61\u201373. https:\/\/doi.org\/10.1111\/j.1747-4949.2011.00731.x","journal-title":"Int J Stroke"},{"key":"13434_CR48","doi-asserted-by":"publisher","DOI":"10.1177\/1747493019871915","author":"V Hachinski","year":"2019","unstructured":"Hachinski V, Einh\u00e4upl K, Ganten D et al (2019) Special topic section: linkages among cerebrovascular, cardiovascular, and cognitive disorders: Preventing dementia by preventing stroke: The Berlin Manifesto. Int J Stroke. https:\/\/doi.org\/10.1177\/1747493019871915","journal-title":"Int J Stroke"},{"key":"13434_CR49","doi-asserted-by":"publisher","DOI":"10.1016\/j.archger.2022.104853","volume":"105","author":"Y Chen","year":"2023","unstructured":"Chen Y, Zhang Y, Li S et al (2023) Cardiometabolic diseases, polygenic risk score, APOE genotype, and risk of incident dementia: a population-based prospective cohort study. Arch Gerontol Geriatr 105:104853. https:\/\/doi.org\/10.1016\/j.archger.2022.104853","journal-title":"Arch Gerontol Geriatr"},{"issue":"1","key":"13434_CR50","doi-asserted-by":"publisher","first-page":"216","DOI":"10.1186\/s12916-024-03424-w","volume":"22","author":"R Luo","year":"2024","unstructured":"Luo R, Zeraatkar D, Glymour M, Ellis RJ, Estiri H, Patel CJ (2024) Specification curve analysis to identify heterogeneity in risk factors for dementia: findings from the UK biobank. BMC Med 22(1):216. https:\/\/doi.org\/10.1186\/s12916-024-03424-w","journal-title":"BMC Med"},{"issue":"3","key":"13434_CR51","doi-asserted-by":"publisher","first-page":"223","DOI":"10.1097\/wad.0000000000000442","volume":"35","author":"CS Kaufman","year":"2021","unstructured":"Kaufman CS, Morris JK, Vidoni ED, Burns JM, Billinger SA (2021) Apolipoprotein E4 moderates the association between vascular risk factors and brain pathology. Alzheimer Dis Assoc Disord 35(3):223\u2013229. https:\/\/doi.org\/10.1097\/wad.0000000000000442","journal-title":"Alzheimer Dis Assoc Disord"},{"key":"13434_CR52","doi-asserted-by":"publisher","first-page":"5","DOI":"10.1016\/j.neurobiolaging.2024.03.006","volume":"139","author":"A Kapoor","year":"2024","unstructured":"Kapoor A, Dutt S, Alitin JPM et al (2024) Older adults with reduced cerebrovascular reactivity exhibit high white matter hyperintensity burden. Neurobiol Aging 139:5\u201310. https:\/\/doi.org\/10.1016\/j.neurobiolaging.2024.03.006","journal-title":"Neurobiol Aging"},{"issue":"5","key":"13434_CR53","doi-asserted-by":"publisher","first-page":"935","DOI":"10.1002\/ana.25228","volume":"83","author":"KB Rajan","year":"2018","unstructured":"Rajan KB, Barnes LL, Wilson RS, Weuve J, McAninch EA, Evans DA (2018) Blood pressure and risk of incident Alzheimer\u2019s disease dementia by antihypertensive medications and APOE \u03b54 allele. Ann Neurol 83(5):935\u2013944. https:\/\/doi.org\/10.1002\/ana.25228","journal-title":"Ann Neurol"},{"issue":"4","key":"13434_CR54","doi-asserted-by":"publisher","first-page":"277","DOI":"10.1007\/s11906-009-0047-0","volume":"11","author":"R Peters","year":"2009","unstructured":"Peters R, Beckett N (2009) Hypertension, dementia, and antihypertensive treatment: implications for the very elderly. Curr Hypertens Rep 11(4):277\u2013282. https:\/\/doi.org\/10.1007\/s11906-009-0047-0","journal-title":"Curr Hypertens Rep"},{"issue":"1","key":"13434_CR55","doi-asserted-by":"publisher","first-page":"278","DOI":"10.1016\/j.atherosclerosis.2009.09.010","volume":"209","author":"MG Kaya","year":"2010","unstructured":"Kaya MG, Yarlioglues M, Gunebakmaz O et al (2010) Platelet activation and inflammatory response in patients with non-dipper hypertension. Atherosclerosis 209(1):278\u2013282. https:\/\/doi.org\/10.1016\/j.atherosclerosis.2009.09.010","journal-title":"Atherosclerosis"},{"issue":"7806","key":"13434_CR56","doi-asserted-by":"publisher","first-page":"71","DOI":"10.1038\/s41586-020-2247-3","volume":"581","author":"A Montagne","year":"2020","unstructured":"Montagne A, Nation DA, Sagare AP et al (2020) APOE4 leads to blood-brain barrier dysfunction predicting cognitive decline. Nature 581(7806):71\u201376. https:\/\/doi.org\/10.1038\/s41586-020-2247-3","journal-title":"Nature"},{"issue":"2","key":"13434_CR57","doi-asserted-by":"publisher","first-page":"155","DOI":"10.1016\/j.diabres.2005.10.004","volume":"72","author":"X Guangda","year":"2006","unstructured":"Guangda X, Linshuang Z, Jie H, Ling Y, Huijuan X (2006) Apo e4 allele is associated with endothelium-dependent arterial dilation in women with type 2 diabetes. Diabetes Res Clin Pract 72(2):155\u2013161. https:\/\/doi.org\/10.1016\/j.diabres.2005.10.004","journal-title":"Diabetes Res Clin Pract"},{"issue":"2","key":"13434_CR58","doi-asserted-by":"publisher","first-page":"276","DOI":"10.1111\/jgs.13235","volume":"63","author":"I Hajjar","year":"2015","unstructured":"Hajjar I, Sorond F, Lipsitz LA (2015) Apolipoprotein E, carbon dioxide vasoreactivity, and cognition in older adults: effect of hypertension. J Am Geriatr Soc 63(2):276\u2013281. https:\/\/doi.org\/10.1111\/jgs.13235","journal-title":"J Am Geriatr Soc"},{"issue":"1","key":"13434_CR59","doi-asserted-by":"publisher","first-page":"93","DOI":"10.1001\/archneurol.2009.913","volume":"67","author":"M Thambisetty","year":"2010","unstructured":"Thambisetty M, Beason-Held L, An Y, Kraut MA, Resnick SM (2010) APOE epsilon4 genotype and longitudinal changes in cerebral blood flow in normal aging. Arch Neurol 67(1):93\u201398. https:\/\/doi.org\/10.1001\/archneurol.2009.913","journal-title":"Arch Neurol"},{"issue":"7","key":"13434_CR60","doi-asserted-by":"publisher","first-page":"1110","DOI":"10.1016\/j.neuron.2024.01.008","volume":"112","author":"A Chemparathy","year":"2024","unstructured":"Chemparathy A, Le Guen Y, Chen S et al (2024) APOE loss-of-function variants: compatible with longevity and associated with resistance to Alzheimer\u2019s disease pathology. Neuron 112(7):1110-1116.e5. https:\/\/doi.org\/10.1016\/j.neuron.2024.01.008","journal-title":"Neuron"},{"issue":"1","key":"13434_CR61","doi-asserted-by":"publisher","first-page":"4695","DOI":"10.1038\/s41467-024-49028-z","volume":"15","author":"Z Xia","year":"2024","unstructured":"Xia Z, Prescott EE, Urbanek A et al (2024) Co-aggregation with apolipoprotein E modulates the function of Amyloid-\u03b2 in Alzheimer\u2019s disease. Nat Commun 15(1):4695. https:\/\/doi.org\/10.1038\/s41467-024-49028-z","journal-title":"Nat Commun"},{"issue":"13","key":"13434_CR62","doi-asserted-by":"publisher","first-page":"2213","DOI":"10.1016\/j.cell.2022.05.017","volume":"185","author":"J Tcw","year":"2022","unstructured":"Tcw J, Qian L, Pipalia NH et al (2022) Cholesterol and matrisome pathways dysregulated in astrocytes and microglia. Cell 185(13):2213-2233.e25. https:\/\/doi.org\/10.1016\/j.cell.2022.05.017","journal-title":"Cell"},{"issue":"4","key":"13434_CR63","doi-asserted-by":"publisher","first-page":"159","DOI":"10.1159\/000078501","volume":"23","author":"CA Szekely","year":"2004","unstructured":"Szekely CA, Thorne JE, Zandi PP et al (2004) Nonsteroidal anti-inflammatory drugs for the prevention of Alzheimer\u2019s disease: a systematic review. Neuroepidemiology 23(4):159\u2013169. https:\/\/doi.org\/10.1159\/000078501","journal-title":"Neuroepidemiology"},{"issue":"3","key":"13434_CR64","doi-asserted-by":"publisher","first-page":"626","DOI":"10.1212\/wnl.48.3.626","volume":"48","author":"WF Stewart","year":"1997","unstructured":"Stewart WF, Kawas C, Corrada M, Metter EJ (1997) Risk of Alzheimer\u2019s disease and duration of NSAID use. Neurology 48(3):626\u2013632. https:\/\/doi.org\/10.1212\/wnl.48.3.626","journal-title":"Neurology"},{"issue":"21","key":"13434_CR65","doi-asserted-by":"publisher","first-page":"1515","DOI":"10.1056\/NEJMoa010178","volume":"345","author":"BA in t\u2019 Veld","year":"2001","unstructured":"in t\u2019 Veld BA, Ruitenberg A, Hofman A et al (2001) Nonsteroidal antiinflammatory drugs and the risk of Alzheimer\u2019s disease. N Engl J Med 345(21):1515\u20131521. https:\/\/doi.org\/10.1056\/NEJMoa010178","journal-title":"N Engl J Med"},{"issue":"2","key":"13434_CR66","doi-asserted-by":"publisher","first-page":"425","DOI":"10.1212\/wnl.47.2.425","volume":"47","author":"PL McGeer","year":"1996","unstructured":"McGeer PL, Schulzer M, McGeer EG (1996) Arthritis and anti-inflammatory agents as possible protective factors for Alzheimer\u2019s disease: a review of 17 epidemiologic studies. Neurology 47(2):425\u2013432. https:\/\/doi.org\/10.1212\/wnl.47.2.425","journal-title":"Neurology"},{"issue":"19","key":"13434_CR67","doi-asserted-by":"publisher","first-page":"1672","DOI":"10.1212\/01.wnl.0000311269.57716.63","volume":"70","author":"SC Vlad","year":"2008","unstructured":"Vlad SC, Miller DR, Kowall NW, Felson DT (2008) Protective effects of NSAIDs on the development of Alzheimer disease. Neurology 70(19):1672\u20131677. https:\/\/doi.org\/10.1212\/01.wnl.0000311269.57716.63","journal-title":"Neurology"},{"issue":"4","key":"13434_CR68","doi-asserted-by":"publisher","first-page":"402","DOI":"10.1016\/j.jalz.2010.12.014","volume":"7","author":"JC Breitner","year":"2011","unstructured":"Breitner JC, Baker LD, Montine TJ et al (2011) Extended results of the Alzheimer\u2019s disease anti-inflammatory prevention trial. Alzheimers Dement 7(4):402\u2013411. https:\/\/doi.org\/10.1016\/j.jalz.2010.12.014","journal-title":"Alzheimers Dement"},{"issue":"6860","key":"13434_CR69","doi-asserted-by":"publisher","first-page":"212","DOI":"10.1038\/35102591","volume":"414","author":"S Weggen","year":"2001","unstructured":"Weggen S, Eriksen JL, Das P et al (2001) A subset of NSAIDs lower amyloidogenic Abeta42 independently of cyclooxygenase activity. Nature 414(6860):212\u2013216. https:\/\/doi.org\/10.1038\/35102591","journal-title":"Nature"},{"issue":"3","key":"13434_CR70","doi-asserted-by":"publisher","first-page":"440","DOI":"10.1172\/jci18162","volume":"112","author":"JL Eriksen","year":"2003","unstructured":"Eriksen JL, Sagi SA, Smith TE et al (2003) NSAIDs and enantiomers of flurbiprofen target gamma-secretase and lower Abeta 42 in vivo. J Clin Invest 112(3):440\u2013449. https:\/\/doi.org\/10.1172\/jci18162","journal-title":"J Clin Invest"},{"issue":"7937","key":"13434_CR71","doi-asserted-by":"publisher","first-page":"769","DOI":"10.1038\/s41586-022-05439-w","volume":"611","author":"JW Blanchard","year":"2022","unstructured":"Blanchard JW, Akay LA, Davila-Velderrain J et al (2022) APOE4 impairs myelination via cholesterol dysregulation in oligodendrocytes. Nature 611(7937):769\u2013779. https:\/\/doi.org\/10.1038\/s41586-022-05439-w","journal-title":"Nature"},{"issue":"1","key":"13434_CR72","doi-asserted-by":"publisher","DOI":"10.1186\/s13195-023-01251-4","volume":"15","author":"A Vipin","year":"2023","unstructured":"Vipin A, Kumar D, Soo SA et al (2023) APOE4 carrier status determines association between white matter disease and grey matter atrophy in early-stage dementia. Alzheimers Res Ther 15(1):103. https:\/\/doi.org\/10.1186\/s13195-023-01251-4","journal-title":"Alzheimers Res Ther"},{"key":"13434_CR73","doi-asserted-by":"publisher","DOI":"10.3389\/fneur.2021.735036","volume":"12","author":"DS Powell","year":"2021","unstructured":"Powell DS, Kuo PL, Qureshi R et al (2021) The relationship of APOE \u03b54, race, and sex on the age of onset and risk of dementia. Front Neurol 12:735036. https:\/\/doi.org\/10.3389\/fneur.2021.735036","journal-title":"Front Neurol"},{"issue":"3","key":"13434_CR74","doi-asserted-by":"publisher","first-page":"221","DOI":"10.3233\/jad-2004-6302","volume":"6","author":"MS Burkhardt","year":"2004","unstructured":"Burkhardt MS, Foster JK, Laws SM et al (2004) Oestrogen replacement therapy may improve memory functioning in the absence of APOE epsilon4. J Alzheimers Dis 6(3):221\u2013228. https:\/\/doi.org\/10.3233\/jad-2004-6302","journal-title":"J Alzheimers Dis"},{"issue":"9","key":"13434_CR75","doi-asserted-by":"publisher","first-page":"929","DOI":"10.1001\/jamaneurol.2023.2169","volume":"80","author":"S Walters","year":"2023","unstructured":"Walters S, Contreras AG, Eissman JM et al (2023) Associations of sex, race, and apolipoprotein E alleles with multiple domains of cognition among older adults. JAMA Neurol 80(9):929\u2013939. https:\/\/doi.org\/10.1001\/jamaneurol.2023.2169","journal-title":"JAMA Neurol"},{"issue":"1","key":"13434_CR76","doi-asserted-by":"publisher","first-page":"41","DOI":"10.1093\/gerona\/glaa247","volume":"76","author":"N Lamonja-Vicente","year":"2021","unstructured":"Lamonja-Vicente N, Dacosta-Aguayo R, L\u00f3pez-Ol\u00f3riz J et al (2021) Sex-specific protective effects of APOE \u03b52 on cognitive performance. J Gerontol A Biol Sci Med Sci 76(1):41\u201349. https:\/\/doi.org\/10.1093\/gerona\/glaa247","journal-title":"J Gerontol A Biol Sci Med Sci"},{"issue":"9303","key":"13434_CR77","doi-asserted-by":"publisher","first-page":"281","DOI":"10.1016\/s0140-6736(02)07493-7","volume":"359","author":"A Ruitenberg","year":"2002","unstructured":"Ruitenberg A, van Swieten JC, Witteman JC et al (2002) Alcohol consumption and risk of dementia: the Rotterdam study. Lancet 359(9303):281\u2013286. https:\/\/doi.org\/10.1016\/s0140-6736(02)07493-7","journal-title":"Lancet"},{"key":"13434_CR78","doi-asserted-by":"publisher","DOI":"10.3390\/nu16203431","author":"V Boccardi","year":"2024","unstructured":"Boccardi V, Tagliafico L, Persia A et al (2024) The potential effects of red wine and its components on neurocognitive disorders: a narrative review. Nutrients. https:\/\/doi.org\/10.3390\/nu16203431","journal-title":"Nutrients"},{"issue":"12","key":"13434_CR79","doi-asserted-by":"publisher","first-page":"1218","DOI":"10.1002\/gps.3772","volume":"27","author":"F Panza","year":"2012","unstructured":"Panza F, Frisardi V, Seripa D et al (2012) Alcohol consumption in mild cognitive impairment and dementia: harmful or neuroprotective? Int J Geriatr Psychiatry 27(12):1218\u20131238. https:\/\/doi.org\/10.1002\/gps.3772","journal-title":"Int J Geriatr Psychiatry"},{"issue":"2","key":"13434_CR80","doi-asserted-by":"publisher","first-page":"509","DOI":"10.3233\/jad-190834","volume":"74","author":"M Koch","year":"2020","unstructured":"Koch M, Costanzo S, Fitzpatrick AL et al (2020) Alcohol consumption, brain amyloid-\u03b2 deposition, and brain structural integrity among older adults free of dementia. J Alzheimers Dis 74(2):509\u2013519. https:\/\/doi.org\/10.3233\/jad-190834","journal-title":"J Alzheimers Dis"},{"key":"13434_CR81","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.neulet.2017.11.038","volume":"665","author":"J Li","year":"2018","unstructured":"Li J, Cheng J (2018) Apolipoprotein E4 exacerbates ethanol-induced neurotoxicity through augmentation of oxidative stress and apoptosis in N2a-APP cells. Neurosci Lett 665:1\u20136. https:\/\/doi.org\/10.1016\/j.neulet.2017.11.038","journal-title":"Neurosci Lett"},{"key":"13434_CR82","doi-asserted-by":"publisher","DOI":"10.1016\/j.neuropharm.2021.108556","volume":"196","author":"KM Serafine","year":"2021","unstructured":"Serafine KM, O\u2019Dell LE, Zorrilla EP (2021) Converging vulnerability factors for compulsive food and drug use. Neuropharmacology 196:108556. https:\/\/doi.org\/10.1016\/j.neuropharm.2021.108556","journal-title":"Neuropharmacology"},{"issue":"9","key":"13434_CR83","doi-asserted-by":"publisher","DOI":"10.1001\/jamanetworkopen.2020.16084","volume":"3","author":"M Kivim\u00e4ki","year":"2020","unstructured":"Kivim\u00e4ki M, Singh-Manoux A, Batty GD et al (2020) Association of alcohol-induced loss of consciousness and overall alcohol consumption with risk for dementia. JAMA Netw Open 3(9):e2016084. https:\/\/doi.org\/10.1001\/jamanetworkopen.2020.16084","journal-title":"JAMA Netw Open"},{"key":"13434_CR84","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1146\/annurev-food-032519-051827","volume":"11","author":"HFJ Hendriks","year":"2020","unstructured":"Hendriks HFJ (2020) Alcohol and human health: what is the evidence? Annu Rev Food Sci Technol 11:1\u201321. https:\/\/doi.org\/10.1146\/annurev-food-032519-051827","journal-title":"Annu Rev Food Sci Technol"},{"key":"13434_CR85","doi-asserted-by":"publisher","DOI":"10.1016\/j.eclinm.2023.102247","volume":"64","author":"F Yi","year":"2023","unstructured":"Yi F, Zhang Y, Yuan J et al (2023) Identifying underlying patterns in Alzheimer\u2019s disease trajectory: a deep learning approach and Mendelian randomization analysis. EClinicalMedicine 64:102247. https:\/\/doi.org\/10.1016\/j.eclinm.2023.102247","journal-title":"EClinicalMedicine"},{"key":"13434_CR86","doi-asserted-by":"publisher","DOI":"10.1016\/j.arr.2023.102178","volume":"93","author":"P Rawat","year":"2024","unstructured":"Rawat P, Sehar U, Bisht J, Reddy AP, Reddy PH (2024) Alzheimer\u2019s disease and Alzheimer\u2019s disease-related dementias in Hispanics: identifying influential factors and supporting caregivers. Ageing Res Rev 93:102178. https:\/\/doi.org\/10.1016\/j.arr.2023.102178","journal-title":"Ageing Res Rev"},{"key":"13434_CR87","doi-asserted-by":"publisher","DOI":"10.3390\/antiox13020191","author":"Z Fi\u0161ar","year":"2024","unstructured":"Fi\u0161ar Z, Hroudov\u00e1 J (2024) CoQ(10) and mitochondrial dysfunction in Alzheimer\u2019s disease. Antioxidants. https:\/\/doi.org\/10.3390\/antiox13020191","journal-title":"Antioxidants"},{"issue":"7465","key":"13434_CR88","doi-asserted-by":"publisher","first-page":"539","DOI":"10.1136\/bmj.38181.418958.BE","volume":"329","author":"T Anttila","year":"2004","unstructured":"Anttila T, Helkala EL, Viitanen M et al (2004) Alcohol drinking in middle age and subsequent risk of mild cognitive impairment and dementia in old age: a prospective population based study. BMJ 329(7465):539. https:\/\/doi.org\/10.1136\/bmj.38181.418958.BE","journal-title":"BMJ"},{"issue":"3","key":"13434_CR89","doi-asserted-by":"publisher","first-page":"280","DOI":"10.1097\/00001648-200005000-00009","volume":"11","author":"C Dufouil","year":"2000","unstructured":"Dufouil C, Tzourio C, Brayne C, Berr C, Amouyel P, Alp\u00e9rovitch A (2000) Influence of apolipoprotein E genotype on the risk of cognitive deterioration in moderate drinkers and smokers. Epidemiology 11(3):280\u2013284. https:\/\/doi.org\/10.1097\/00001648-200005000-00009","journal-title":"Epidemiology"},{"issue":"9","key":"13434_CR90","doi-asserted-by":"publisher","first-page":"1027","DOI":"10.1001\/jama.300.9.1027","volume":"300","author":"NT Lautenschlager","year":"2008","unstructured":"Lautenschlager NT, Cox KL, Flicker L et al (2008) Effect of physical activity on cognitive function in older adults at risk for Alzheimer disease: a randomized trial. JAMA 300(9):1027\u20131037. https:\/\/doi.org\/10.1001\/jama.300.9.1027","journal-title":"JAMA"},{"key":"13434_CR91","doi-asserted-by":"publisher","DOI":"10.1093\/cercor\/bhae205","author":"K Igloi","year":"2024","unstructured":"Igloi K, Marin Bosch B, Kuenzi N et al (2024) Interactions between physical exercise, associative memory, and genetic risk for Alzheimer\u2019s disease. Cereb Cortex. https:\/\/doi.org\/10.1093\/cercor\/bhae205","journal-title":"Cereb Cortex"},{"issue":"10","key":"13434_CR92","doi-asserted-by":"publisher","DOI":"10.1136\/bmjopen-2016-014706","volume":"7","author":"W Xu","year":"2017","unstructured":"Xu W, Wang HF, Wan Y, Tan CC, Yu JT, Tan L (2017) Leisure time physical activity and dementia risk: a dose-response meta-analysis of prospective studies. BMJ Open 7(10):e014706. https:\/\/doi.org\/10.1136\/bmjopen-2016-014706","journal-title":"BMJ Open"},{"issue":"6","key":"13434_CR93","doi-asserted-by":"publisher","first-page":"1096","DOI":"10.1016\/j.ajcnut.2023.04.001","volume":"117","author":"BZ Wei","year":"2023","unstructured":"Wei BZ, Li L, Dong CW, Tan CC, Xu W (2023) The relationship of omega-3 fatty acids with dementia and cognitive decline: evidence from prospective cohort studies of supplementation, dietary intake, and blood markers. Am J Clin Nutr 117(6):1096\u20131109. https:\/\/doi.org\/10.1016\/j.ajcnut.2023.04.001","journal-title":"Am J Clin Nutr"},{"issue":"6","key":"13434_CR94","doi-asserted-by":"publisher","first-page":"261","DOI":"10.1016\/j.plefa.2014.09.007","volume":"91","author":"V Conway","year":"2014","unstructured":"Conway V, Larouche A, Alata W, Vandal M, Calon F, Plourde M (2014) Apolipoprotein E isoforms disrupt long-chain fatty acid distribution in the plasma, the liver and the adipose tissue of mice. Prostaglandins Leukot Essent Fatty Acids 91(6):261\u2013267. https:\/\/doi.org\/10.1016\/j.plefa.2014.09.007","journal-title":"Prostaglandins Leukot Essent Fatty Acids"},{"issue":"6","key":"13434_CR95","doi-asserted-by":"publisher","DOI":"10.1016\/j.jlr.2023.100354","volume":"64","author":"MA Bantugan","year":"2023","unstructured":"Bantugan MA, Xian H, Solomon V et al (2023) Associations of ApoE4 status and DHA supplementation on plasma and CSF lipid profiles and entorhinal cortex thickness. J Lipid Res 64(6):100354. https:\/\/doi.org\/10.1016\/j.jlr.2023.100354","journal-title":"J Lipid Res"},{"issue":"8","key":"13434_CR96","doi-asserted-by":"publisher","DOI":"10.1001\/jamanetworkopen.2024.26872","volume":"7","author":"LH Shinto","year":"2024","unstructured":"Shinto LH, Murchison CF, Silbert LC et al (2024) \u03c9-3 PUFA for secondary prevention of white matter lesions and neuronal integrity breakdown in older adults: a randomized clinical trial. JAMA Netw Open 7(8):e2426872. https:\/\/doi.org\/10.1001\/jamanetworkopen.2024.26872","journal-title":"JAMA Netw Open"},{"issue":"1","key":"13434_CR97","doi-asserted-by":"publisher","first-page":"462","DOI":"10.1186\/s12916-025-04255-z","volume":"23","author":"LY Huang","year":"2025","unstructured":"Huang LY, Tan L, Tan CC et al (2025) Sleep quality, APOE \u03b54, and Alzheimer\u2019s disease: associations from two prospective cohort studies and mechanisms by plasma proteomic analysis. BMC Med 23(1):462. https:\/\/doi.org\/10.1186\/s12916-025-04255-z","journal-title":"BMC Med"},{"issue":"3","key":"13434_CR98","doi-asserted-by":"publisher","first-page":"667","DOI":"10.3233\/jad-2011-111265","volume":"28","author":"Z Kariv-Inbal","year":"2012","unstructured":"Kariv-Inbal Z, Yacobson S, Berkecz R et al (2012) The isoform-specific pathological effects of apoE4 in vivo are prevented by a fish oil (DHA) diet and are modified by cholesterol. J Alzheimers Dis 28(3):667\u2013683. https:\/\/doi.org\/10.3233\/jad-2011-111265","journal-title":"J Alzheimers Dis"},{"key":"13434_CR99","doi-asserted-by":"publisher","first-page":"28","DOI":"10.1016\/j.neurobiolaging.2017.05.003","volume":"57","author":"R Chouinard-Watkins","year":"2017","unstructured":"Chouinard-Watkins R, Vandal M, L\u00e9veill\u00e9 P, Pin\u00e7on A, Calon F, Plourde M (2017) Docosahexaenoic acid prevents cognitive deficits in human apolipoprotein E epsilon 4-targeted replacement mice. Neurobiol Aging 57:28\u201335. https:\/\/doi.org\/10.1016\/j.neurobiolaging.2017.05.003","journal-title":"Neurobiol Aging"},{"issue":"3","key":"13434_CR100","doi-asserted-by":"publisher","first-page":"408","DOI":"10.1002\/alz.12405","volume":"18","author":"AA Baril","year":"2022","unstructured":"Baril AA, Beiser AS, Sanchez E et al (2022) Insomnia symptom severity and cognitive performance: moderating role of APOE genotype. Alzheimers Dement 18(3):408\u2013421. https:\/\/doi.org\/10.1002\/alz.12405","journal-title":"Alzheimers Dement"},{"issue":"13","key":"13434_CR101","doi-asserted-by":"publisher","first-page":"e1167","DOI":"10.1212\/wnl.0000000000005193","volume":"90","author":"JY Hwang","year":"2018","unstructured":"Hwang JY, Byun MS, Choe YM et al (2018) Moderating effect of APOE \u03b54 on the relationship between sleep-wake cycle and brain \u03b2-amyloid. Neurology 90(13):e1167\u2013e1173. https:\/\/doi.org\/10.1212\/wnl.0000000000005193","journal-title":"Neurology"},{"issue":"5","key":"13434_CR102","doi-asserted-by":"publisher","first-page":"1385","DOI":"10.1111\/ene.15269","volume":"29","author":"H Duan","year":"2022","unstructured":"Duan H, Sun Y, Liu Q et al (2022) Apolipoprotein E polymorphism \u03b54-stratified longitudinal association between daytime naps, sleep apnea and mild cognitive impairment: a prospective cohort study. Eur J Neurol 29(5):1385\u20131393. https:\/\/doi.org\/10.1111\/ene.15269","journal-title":"Eur J Neurol"},{"issue":"12","key":"13434_CR103","doi-asserted-by":"publisher","first-page":"2472","DOI":"10.1111\/jgs.14393","volume":"64","author":"X Ding","year":"2016","unstructured":"Ding X, Kryscio RJ, Turner J et al (2016) Self-reported sleep apnea and dementia risk: findings from the prevention of Alzheimer\u2019s disease with vitamin E and selenium trial. J Am Geriatr Soc 64(12):2472\u20132478. https:\/\/doi.org\/10.1111\/jgs.14393","journal-title":"J Am Geriatr Soc"},{"issue":"10","key":"13434_CR104","doi-asserted-by":"publisher","first-page":"1446","DOI":"10.1038\/s43587-024-00693-1","volume":"4","author":"EA Frick","year":"2024","unstructured":"Frick EA, Emilsson V, Jonmundsson T et al (2024) Serum proteomics reveal APOE-\u03b54-dependent and APOE-\u03b54-independent protein signatures in Alzheimer\u2019s disease. Nat Aging 4(10):1446\u20131464. https:\/\/doi.org\/10.1038\/s43587-024-00693-1","journal-title":"Nat Aging"}],"container-title":["Journal of Neurology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00415-025-13434-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00415-025-13434-0\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00415-025-13434-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,29]],"date-time":"2025-10-29T01:04:23Z","timestamp":1761699863000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00415-025-13434-0"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,10]]},"references-count":104,"journal-issue":{"issue":"10","published-print":{"date-parts":[[2025,10]]}},"alternative-id":["13434"],"URL":"https:\/\/doi.org\/10.1007\/s00415-025-13434-0","relation":{},"ISSN":["0340-5354","1432-1459"],"issn-type":[{"value":"0340-5354","type":"print"},{"value":"1432-1459","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,10]]},"assertion":[{"value":"11 July 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"27 September 2025","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"1 October 2025","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"13 October 2025","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare that they have no competing interests.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}}],"article-number":"690"}}